Anti-OX40L antibodies and methods of treating graft versus host disease
US10669342B2 · kind B2 · utility
4Cited by
18References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 3, 2015 |
| Grant date | Jun 2, 2020 |
| Priority date | — |
| Expiry date | Dec 12, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to anti-human OX4OL antibodies, new medical uses and methods.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.